/ RAPT
/ Market Analysis
Why Is RAPT Stock Skyrocketing Today? GSK’s $2.2B Offer Drives Rally
RAPT Therapeutics stock surged over 63% after GSK agreed to buy the company for $58 per share in a $2.2 billion deal.
January 20, 2026